Quest Diagnostics Inc. closed 8.28% below its 52-week high of $178.87, which the company reached on March 10th.

Shares of Quest Diagnostics Inc. DGX slid 2.74% to $159.80 Tuesday, on what proved to be an all-around dismal trading session ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Shares of Quest Diagnostics Incorporated (NYSE ... Seven investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and two have given a strong ...

Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses on ...

Quest Diagnostics Inc. DGX benefits from its robust ... A strong focus on operational excellence is highly encouraging for the stock. Meanwhile, the adverse impacts of the broader industry ...

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling. Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be ...

Quest Diagnostics reported revenues of $2.49 billion for Q3 2024, outperforming analyst expectations of $2.425 billion. Adjusted diluted earnings per share (EPS) reached $2.30, also surpassing the ...

Cash flow from operations fell by 18.9%, showing underlying operational challenges. Quest Diagnostics is a leading provider of diagnostic tests -- ranging from allergies to cancer -- in the United ...

Strategic outreach acquisitions and a strong focus on driving operational improvements further bode well for the stock. Secaucus, NJ-based Quest Diagnostics provides a broad range of diagnostic ...

stock has rallied 38% compared with the industry’s 9.7% growth and the S&P 500 composite’s 19.6% rise. The renowned provider of diagnostic information services has a market capitalization of $19.11 ...